With state-of-the-art clinical and commercial manufacturing facilities across the United States, Europe, and Asia, AGC Biologics has the capacity and flexibility to meet each customer’s individual manufacturing needs. Our manufacturing facilities are multi-process, engineered for unilateral flow, and segregated to produce multiple products at different stages of manufacturing in multiple parts of the facility. This increases the flexibility and number of manufacturing solutions available to meet clients’ rigorous manufacturing and quality needs. Right. On Time.
Our multi-purpose, highly-efficient Chiba facility is compatible with diverse processes, with a core structure and gravity-based facility design that guarantees flexibility and high quality.
This facility offers vast experience with cGMP manufacturing in a large number of projects ranging from E. coli to yeasts.
TECHNOLOGIES
AGC Biologics
General Inquiries: contact@agcbio.com
Seattle (Headquarters)
22021 20th Avenue SE
Bothell, WA 98021 USA
+1 425 485 1900
Berkeley
890 Heinz Avenue
Berkeley, CA 94710 USA
+1 425 485 1900
Copenhagen
Vandtaarnsvej 83B, DK-2860 Soeborg
Copenhagen, Denmark
CVR: 25950941
+45 7020 9470
CMC Biologics A/S, dba AGC Biologics, CVR no. 25950941
Heidelberg
Czernyring 22
69115 Heidelberg, Germany
+49 6221 90260
BIOMEVA GmbH Geschaeftsfuehrer / Managing Director: Yukiteru Nakashita Sitz der Gesellschaft / Registered office: Heidelberg Registergericht / Register court: Mannheim HRB 335606
Yokohama
1150, Hazawacho, Kanagawa-ku
Yokohama 221-8755 Japan
+81 3 3218 5694
Chiba
10, Goikaigan, Ichihara City
Chiba 290-8566 Japan
+81 3 3218 5694
©2018 AGC Biologics. All Rights Reserved.
